Bucladesine Sodium

布拉地新钠

Report date: 2025/12/09 10:25:30
NME

Base Information

Drug NameBucladesine Sodium
Drug Alias Name二丁酰环磷腺苷bucladesina布拉地辛钠bucladesinum二丁酰环磷腺苷钠 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPressure Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesNipro Patch Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNipro Patch Co Ltd
Active IndicationsPressure Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeC01CE04
Related LinksWikipediaKEGG